Newsletter Archive

21. 04.24.26 -- STREAM Edition: Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D. 4/24/2026

    04/24/26 Bioprocess Online Newsletter

22. 04.24.26 -- Green Supply Chains Rarely Start With A Pledge; Target Waste Instead 4/24/2026
    04/24/26 Bioprocess Online Newsletter
23. 04.23.26 -- Quantifying Single-Use Waste Produced During mAb Manufacture 4/23/2026
    04/23/26 Bioprocess Online Newsletter
24. 04.22.26 -- Building Resilient Biomanufacturing From Media To Market 4/22/2026

    04/22/26 Bioprocess Online Newsletter

25. 04.22.26 -- Technological advances in biosafety testing which will de-risk and reduce your regulatory timelines 4/22/2026

    04/22/26 Bioprocess Online Newsletter

26. 04.22.26 -- Drug-Device Combination Products: 4 Evolving Platforms For 2026 4/22/2026
    04/22/26 Bioprocess Online Newsletter
27. 04.21.26 -- Where Bioprocess Automation Is Headed 4/21/2026

    04/21/26 Bioprocess Online Newsletter

28. 04.21.26 -- What If The U.S. Government Stopped Funding Biotech? 4/21/2026
    04/21/26 Bioprocess Online Newsletter
29. 04.20.26 -- New Research: Co-Expression Could Make Plant-Based Systems Viable 4/20/2026
    04/20/26 Bioprocess Online Newsletter
30. 04.17.26 -- STREAM Edition: Reprogramming T Cells And Reducing Manufacturing Costs With RegCell's Michael McCullar, Ph.D. 4/17/2026

    04/17/26 Bioprocess Online Newsletter